SB
Therapeutic Areas
Neurolief Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Relivion MG | Acute and chronic migraine | Commercial |
| Proliv™Rx | Major depressive disorder | Phase 2 |
Leadership Team at Neurolief
SD
Scott Drees
Chief Executive Officer
AD
Amit Dar
Chief Technology Officer
TB
Tony Borowicz
Chief Financial Officer
RB
Ron Belson
Vice President, Research & Development
DL
Dganit Litinsky
Vice President, Regulatory & Quality
AC
Amir Cohen
Clinical Development Director